Procter & Gamble financials
$148.32−0.48%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Jun 30 | Q3 '26 Mar 31 | Q2 '26 Dec 31 | Q1 '26 Sep 30 | Q4 '25 Jun 30 | Q3 '25 Mar 31 | Q2 '25 Dec 31 | Q1 '25 Sep 30 | Q4 '24 Jun 30 | Q3 '24 Mar 31 | Q2 '24 Dec 31 | Q1 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.20B | $21.23B | $22.21B | $22.39B | $20.89B | $19.78B | $21.88B | $21.74B | $20.53B | $20.20B | $21.44B | $21.87B |
| Gross profit | $10.28B | $10.51B | $11.37B | $11.50B | $10.26B | $10.08B | $11.46B | $11.32B | $10.18B | $10.34B | $11.30B | $11.37B |
| Gross margin | 48.5% | 49.5% | 51.2% | 51.4% | 49.1% | 51.0% | 52.4% | 52.1% | 49.6% | 51.2% | 52.7% | 52.0% |
| Operating income | $3.95B | $4.58B | $5.37B | $5.86B | $4.35B | $4.56B | $5.74B | $5.80B | $3.88B | $4.46B | $4.43B | $5.77B |
| Net income | $2.97B | $3.86B | $4.25B | $4.68B | $3.54B | $3.70B | $4.56B | $3.89B | $3.06B | $3.69B | $3.40B | $4.45B |
| Net margin | 14.0% | 18.2% | 19.1% | 20.9% | 16.9% | 18.7% | 20.8% | 17.9% | 14.9% | 18.2% | 15.8% | 20.3% |
| Diluted EPS | $1.23 | $1.63 | $1.78 | $1.95 | $1.45 | $1.54 | $1.88 | $1.61 | $1.24 | $1.52 | $1.40 | $1.83 |
| EBITDA | $4.76B | $5.36B | $6.17B | $6.62B | $5.08B | $5.25B | $6.45B | $6.53B | $3.88B | $5.17B | $6.50B | $6.47B |
| Operating cash flow | $5.13B | $4.04B | $4.97B | $5.41B | $4.99B | $3.71B | $4.83B | $4.30B | $5.75B | $4.09B | $5.10B | $4.90B |
| Free cash flow | $4.11B | $3.02B | $3.81B | $4.21B | $3.99B | $2.85B | $3.90B | $3.31B | $4.97B | $3.29B | $4.28B | $3.98B |
| Diluted shares | 2,412.7M | 2,416.5M | 2,424.0M | 2,436.8M | 2,443.7M | 2,449.8M | 2,458.1M | 2,466.0M | 2,472.0M | 2,472.0M | 2,468.4M | 2,475.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.94B | $12.31B | $10.82B | $11.17B | $9.56B | $9.12B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $34.14B | $37.03B | $36.64B | $35.95B | $34.51B | $34.14B |
| Total assets | $126.52B | $128.38B | $127.29B | $127.60B | $125.23B | $122.98B |
| Total liabilities | $72.21B | $73.65B | $73.97B | $74.05B | $72.95B | $70.44B |
| Shareholders' equity | $54.31B | $54.73B | $53.32B | $53.55B | $52.28B | $52.55B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology